Behavioral Support to Help You Stay on Buprenorphine
Part of Mental health clinical trials.
This study tests a behavioral support program designed to help people newly starting buprenorphine treatment for opioid use disorder stay engaged with their care. If you've recently started buprenorphine or just been released from incarceration and are beginning treatment, this trial may help you maintain consistent medication use and reduce the risk of relapse.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have opioid use disorder (diagnosed in the past year) and are currently taking buprenorphine
- You started buprenorphine in the last 30 days, or you were released from jail/prison within the last 30 days and are starting buprenorphine now
- You have not used buprenorphine in the 7 days right before starting this treatment episode (or you just started treatment)
- You speak and read English well enough to participate in the study
- You are willing to stay at the same addiction treatment clinic throughout the study and share your medical records with researchers
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether extra support in community settings (like mobile units or outreach) helps people who are starting buprenorphine for opioid use disorder stay on treatment. It focuses on helping you continue your medication and stay healthy.
This study tests whether talking regularly with someone who has recovered from opioid addiction helps you stay in buprenorphine treatment longer. Buprenorphine is a medication that reduces cravings and withdrawal, and peer support may help you stick with it.
This study compares two medications, methadone and buprenorphine, to see which helps people stay in treatment for opioid use disorder. You may be eligible if you are starting a new treatment episode.
This trial tests whether starting buprenorphine using a low-dose plan is a safe and workable way to treat opioid use disorder. You may be able to join if you are 18+, have opioid use disorder, and can follow the study medication and visits.
This trial tests whether a program that combines medication (buprenorphine) with extra support can help people who have had an opioid overdose avoid future overdoses. If you have been seen at UAB Hospital for an opioid overdose, you may be able to join.
This trial tests a long-acting, once-monthly injection of buprenorphine (BRIXADI) given from a mobile pharmacy clinic. It aims to see if this approach is acceptable and practical for people with opioid use disorder, making treatment more accessible.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.